PROSTIN E2 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prostin E2, and when can generic versions of Prostin E2 launch?
Prostin E2 is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in PROSTIN E2 is dinoprostone. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dinoprostone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROSTIN E2?
- What are the global sales for PROSTIN E2?
- What is Average Wholesale Price for PROSTIN E2?
Summary for PROSTIN E2
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Clinical Trials: | 12 |
Patent Applications: | 4,901 |
Drug Prices: | Drug price information for PROSTIN E2 |
DailyMed Link: | PROSTIN E2 at DailyMed |
Recent Clinical Trials for PROSTIN E2
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Medical Centre Maribor | Phase 4 |
Aswan University Hospital | N/A |
Ministry of Health, Singapore | N/A |
US Patents and Regulatory Information for PROSTIN E2
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | PROSTIN E2 | dinoprostone | SUPPOSITORY;VAGINAL | 017810-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROSTIN E2
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | PROSTIN E2 | dinoprostone | SUPPOSITORY;VAGINAL | 017810-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | PROSTIN E2 | dinoprostone | SUPPOSITORY;VAGINAL | 017810-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROSTIN E2
See the table below for patents covering PROSTIN E2 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Philippines | 11063 | METHOD FOR CONTROLLING THE REPRODUCTIVE CYCLE IN AN OVULATING HUMAN | ⤷ Sign Up |
Netherlands | 7017457 | ⤷ Sign Up | |
Israel | 35724 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |